PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.\', \'Biospherix, Lacona, New York, USA.\', \'National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, USA.\', \'RoosterBio, Frederick, Maryland, USA.\', \'Organabio, Miami, Florida, USA.\', \'Orbital Transports, Chicago, Illinois, USA.\', \'PHC Group, Livingston, New Jersey, USA.\', \'Jackson Labs, Mount Desert Island, Maine, USA.\', \'International Perinatal Stem Cell Society, Inc., Westport, Connecticut, USA.\', \'Humabiologics, Inc., Phoenix, Arizona, USA.\', \'Allevi, Philadelphia, Pennsylvania, USA.\', \'Cytiva, Marlborough, Massachusetts, USA.\', \'Regenerative Medicine Manufacturing Society, Winston-Salem, North Carolina, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/sctm.20-0245
?:hasPublicationType
?:journal
  • Stem cells translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 32856432
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.722
?:rankingScore_hIndex
  • 45
?:title
  • Regen med therapeutic opportunities for fighting COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32856432>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32856432>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all